Company news
Nuvo Pharmaceuticals Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Nuvo Research to Present at Upcoming Healthcare Conferences
September 1, 2011
Nuvo Research Announces 2011 Second Quarter Results
August 10, 2011
Nuvo Research Provides Corporate Update
July 20, 2011
Nuvo Research announces marketing authorization application for Pliaglis® validated by European regulatory agencies
July 5, 2011
Nuvo Research announces positive top-line results for PENNSAID Viscous Solution Phase 2 trial
June 30, 2011
Nuvo receives ind clearance from FDA to begin clinical testing of lidocaine spray
June 28, 2011
Nuvo Research announces 2011 first quarter results
May 26, 2011
Nuvo research to present at BioFinance 2011
May 25, 2011
Nuvo research completes its acquisition of ZARS pharma
May 13, 2011
Nuvo research announces agreement to acquire ZARS pharma
April 18, 2011
Nuvo Research announces 2010 fourth quarter and year-end financial results
February 24, 2011
U.S. Pennsaid sales continue to grow
January 10, 2011
Nuvo Research U.S. awarded US$1.3 million in research grants
November 10, 2010
Nuvo Research announces positive top-line WF10 Phase 2 trial results
November 8, 2010
Nuvo Research announces 2010 third quarter financial results
October 27, 2010
Notice of Nuvo research 2010 third quarter results conference call
October 20, 2010
Nuvo Research provides corporate update
September 7, 2010
Nuvo research to present at Rodman & Renshaw 12th annual healthcare conference
September 2, 2010
Nuvo Research announces 2010 second quarter financial results
July 29, 2010
Nuvo Research Inc. and Sprott Inc. Under Current Evaluation
July 22, 2010
Nuvo Research announces 2010 first quarter financial results
April 29, 2010
Nuvo Research announces U.S. availability of PENNSAID
April 27, 2010
Ubika Research has unveiled a new Small Cap Investment Idea for the week
April 22, 2010
Nuvo Research completes redemption of 5% convertible debentures
March 17, 2010
Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial
March 15, 2010
Nuvo Research announces 2009 fourth quarter and year-end financial results
February 19, 2010
Nuvo Research announces early redemption of 5% convertible debentures
February 4, 2010
Nuvo Research announces organizational changes
December 1, 2009
Nuvo research provides WF10 licensing and development update
November 11, 2009
FDA approves Pennsaid(R) Topical Solution
November 5, 2009
Nuvo announces 2009 third quarter financial results
October 28, 2009
Nuvo Research responds to increased trading activity
October 26, 2009
Nuvo announces co-operative drug development project with Germany's Fraunhofer Institute
September 1, 2009
Nuvo Announces 2009 second quarter financial results
August 7, 2009
FDA extends review of Pennsaid(R) diclofenac sodium topical solution
August 4, 2009
Nuvo Research and Covidien sign U.S. license and development agreement for Pennsaid(R) and Pennsaid Plus(R)
June 16, 2009